Since its initial funding through a SCOR grant in 2002, the UCLA Center for Neurovisceral Sciences and Women's Health has pursued the general hypothesis that many functional disorders, including irritable bowel syndrome (IBS) and interstitial cystitis/painful bladder syndrome (IC/PBS), are related to enhanced stress responsiveness, and that the greater prevalence of these syndromes in women is related to sex related differences in responses to perturbations of homeostasis. Building on results generated during the past 2 funding periods, the current proposal aims to apply novel conceptual, technical and analytical tools to address the following interdisciplinary theme, """"""""Sex-Related Individual Differences in Central Stress Response Systems and Their Role in IBS Pathophysiology and Treatment Response."""""""" We propose to test the general hypothesis that subsets of patients can be identified which are characterized by unique clusters of central and peripheral endophenotypes, and which may show differential responsiveness to treatment. The 3 Projects of the SCOR, supported by two scientific Cores will address two overarching themes: 1) Hypothalamic-Pituitary-Adrenal (HPA) axis and central stress systems, and 2) Endophenotype-based subgrouping of IBS patients. We will address these 2 themes through 3 synergistic, translational research Projects, with an emphasis on sex differences. Project 1 will conduct a comprehensive genetic, molecular and functional phenotyping of the HPA axis in IBS patients and healthy controls establish regional brain CRF/CRF1R expression and delineate engagement of central stress circuits in an animal model of IBS. Project 2 will test the hypothesis that chronic stress in IBS is associated with HPA axis dysregulation, increased visceral adipose tissue (VAT) accumulation and circulating adipokines, which modulate HPA axis responsiveness, and mediate regional brain changes. Project 3 will perform comprehensive endophenotyping using biomarkers collected from all 3 Projects within a large group of IBS patients to identify unique clusters of endophenotypes, and distinguish a subgroup with an upregulated CRF/CRF1R signaling system who can be identified by their responsiveness to a selective CRFIR antagonist.

Public Health Relevance

IBS and IC/PBS are common, female predominant visceral pain conditions, but reasons for this gender bias are poorly understood. These stress-sensitive disorders are highly prevalent, can be associated with a poor quality of life and burdened by the lack of consistently effective treatments. The proposal aims to identify the biologic mechanisms that are responsible for increased stress sensitivity in IBS, determine if these biomarkers can identify a subset of patients and predict response to treatment.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Specialized Center (P50)
Project #
2P50DK064539-11
Application #
8343920
Study Section
Special Emphasis Panel (ZRG1-EMNR-Q (50))
Program Officer
Hamilton, Frank A
Project Start
2002-09-30
Project End
2017-08-31
Budget Start
2012-09-07
Budget End
2013-08-31
Support Year
11
Fiscal Year
2012
Total Cost
$970,647
Indirect Cost
$320,647
Name
University of California Los Angeles
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
092530369
City
Los Angeles
State
CA
Country
United States
Zip Code
90095
Tache, Yvette; Larauche, Muriel; Yuan, Pu-Qing et al. (2018) Brain and Gut CRF Signaling: Biological Actions and Role in the Gastrointestinal Tract. Curr Mol Pharmacol 11:51-71
Hoffman, Jill M; Sideri, Aristea; Ruiz, Jonathan J et al. (2018) Mesenteric Adipose-derived Stromal Cells From Crohn's Disease Patients Induce Protective Effects in Colonic Epithelial Cells and Mice With Colitis. Cell Mol Gastroenterol Hepatol 6:1-16
Fang, Kai; Law, Ivy Ka Man; Padua, David et al. (2018) MicroRNA-31-3p Is Involved in Substance P (SP)-Associated Inflammation in Human Colonic Epithelial Cells and Experimental Colitis. Am J Pathol 188:586-599
Henström, Maria; Diekmann, Lena; Bonfiglio, Ferdinando et al. (2018) Functional variants in the sucrase-isomaltase gene associate with increased risk of irritable bowel syndrome. Gut 67:263-270
Videlock, Elizabeth J; Mahurkar-Joshi, Swapna; Hoffman, Jill M et al. (2018) Sigmoid colon mucosal gene expression supports alterations of neuronal signaling in irritable bowel syndrome with constipation. Am J Physiol Gastrointest Liver Physiol 315:G140-G157
Bonfiglio, Ferdinando; Zheng, Tenghao; Garcia-Etxebarria, Koldo et al. (2018) Female-Specific Association Between Variants on Chromosome 9 and Self-Reported Diagnosis of Irritable Bowel Syndrome. Gastroenterology 155:168-179
Park, S H; Naliboff, B D; Shih, W et al. (2018) Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 30:
Martin, Clair R; Osadchiy, Vadim; Kalani, Amir et al. (2018) The Brain-Gut-Microbiome Axis. Cell Mol Gastroenterol Hepatol 6:133-148
Addante, Raymond; Naliboff, Bruce; Shih, Wendy et al. (2018) Predictors of Health-related Quality of Life in Irritable Bowel Syndrome Patients Compared With Healthy Individuals. J Clin Gastroenterol :
Gupta, Arpana; Woodworth, Davis C; Ellingson, Benjamin M et al. (2018) Disease-Related Microstructural Differences in the Brain in Women With Provoked Vestibulodynia. J Pain 19:528.e1-528.e15

Showing the most recent 10 out of 219 publications